AIP
Ameritas Investment Partners Portfolio holdings
AUM
$3.17B
1-Year Return
20.23%
This Quarter Return
+7.62%
1 Year Return
+20.23%
3 Year Return
+87.65%
5 Year Return
+163.29%
10 Year Return
+366.97%
AUM
$2.79B
AUM Growth
+$164M
(+6.2%)
Cap. Flow
-$29.6M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
20.45%
Holding
3,380
New
285
Increased
507
Reduced
861
Closed
337
Top Buys
| 1 |
Aflac
AFL
|
+$2.83M |
| 2 |
Targa Resources
TRGP
|
+$2.75M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$2.53M |
| 4 |
Union Pacific
UNP
|
+$2.36M |
| 5 |
Target
TGT
|
+$2.3M |
Top Sells
| 1 |
Charles River Laboratories
CRL
|
+$5.68M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$3.92M |
| 3 |
PTC
PTC
|
+$3.87M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$3.77M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$3.55M |
Sector Composition
| 1 | Technology | 17.25% |
| 2 | Financials | 10.71% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Healthcare | 9.54% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
1676
The Gap, Inc.
GAP
$8.5B
| $106K | ﹤0.01% |
3,143
| – | – |
|
1677
Codexis
CDXS
$219M
| $105K | ﹤0.01% |
4,645
| – | – |
|
1678
Columbus McKinnon
CMCO
$415M
| $105K | ﹤0.01% |
2,183
+240
| +12% | +$11.5K |
|
1679
Enterprise Financial Services Corp
EFSC
$2.24B
| $105K | ﹤0.01% |
2,267
+311
| +16% | +$14.4K |
|
1680
e.l.f. Beauty
ELF
$7.67B
| $105K | ﹤0.01% |
3,854
| – | – |
|
1681
James River Group
JRVR
$244M
| $105K | ﹤0.01% |
2,807
+281
| +11% | +$10.5K |
|
1682
Nelnet
NNI
$4.46B
| $105K | ﹤0.01% |
1,401
| – | – |
|
1683
Usana Health Sciences
USNA
$557M
| $105K | ﹤0.01% |
1,022
| – | – |
|
1684
Inogen
INGN
$231M
| $104K | ﹤0.01% |
1,598
| – | – |
|
1685
Purple Innovation
PRPL
$114M
| $104K | ﹤0.01% |
3,938
+1,299
| +49% | +$34.3K |
|
1686
TriMas Corp
TRS
$1.59B
| $104K | ﹤0.01% |
3,443
| – | – |
|
|
BSCM
1687
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $104K | ﹤0.01% |
4,829
+7
| +0.1% | +$151 |
|
1688
AAR Corp
AIR
$2.67B
| $103K | ﹤0.01% |
2,667
-262
| -9% | -$10.1K |
|
|
BBT
1689
Beacon Financial Corporation
BBT
$2.17B
| $103K | ﹤0.01% |
3,744
-320
| -8% | -$8.8K |
|
1690
Celldex Therapeutics
CLDX
$1.62B
| $103K | ﹤0.01% |
+3,074
| New | +$103K |
|
1691
MannKind Corp
MNKD
$1.71B
| $103K | ﹤0.01% |
18,965
| – | – |
|
|
IMGN
1692
DELISTED
Immunogen Inc
IMGN
| $103K | ﹤0.01% |
15,644
| – | – |
|
1693
C4 Therapeutics
CCCC
$189M
| $102K | ﹤0.01% |
2,700
+1,806
| +202% | +$68.2K |
|
|
SHYF
1694
DELISTED
The Shyft Group
SHYF
| $102K | ﹤0.01% |
2,714
-301
| -10% | -$11.3K |
|
1695
S&T Bancorp
STBA
$1.5B
| $102K | ﹤0.01% |
3,252
| – | – |
|
1696
Archrock
AROC
$4.29B
| $101K | ﹤0.01% |
11,297
| – | – |
|
1697
Cal-Maine
CALM
$5.37B
| $101K | ﹤0.01% |
2,798
-304
| -10% | -$11K |
|
1698
Conduent
CNDT
$445M
| $101K | ﹤0.01% |
13,421
| – | – |
|
1699
Hanesbrands
HBI
$2.2B
| $101K | ﹤0.01% |
5,429
| – | – |
|
1700
Stride
LRN
$6.91B
| $101K | ﹤0.01% |
3,159
-361
| -10% | -$11.5K |
|